Metal oxide nanoparticles as alternate antibacterial agents against some common pathogens
find their plausible use as an alternate weapon to fight against multi-drug resistant superbugs
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
find their plausible use as an alternate weapon to fight against multi-drug resistant superbugs
antibiotic resistance problem might engage us in a difficult global war against tiny bacterial superbugs. Local efforts to address and manage this problem in various environments will eventually contribute
essential functions like DNA, RNA and protein synthesis. However, the emergence of antibiotic-resistant ?superbugs? has led to an urgent need to develop novel antibacterial drugs. Quorum quenching
fungi that are resistant to drug cause 700,000 death each year. By 2050 superbugs inured to treatments could cause up to 10million deaths annually and costs the global economy
increased antibiotic resistance. Exemplified here, coagulase-positive S. aureus is one of these emerging ?Superbugs? that hijacks the clotting cascade to effectively limit phagocytic immune cell infiltration. In vivo…
treatment of microbial infections has increased the emergence of pan-antibiotic resistant organisms, superbugs. Discovery of new antibiotics is both time and money dependent. Drug repositioning or drug repurposing
Current bactericidal antibiotics are losing their effectiveness against the rapidly growing drug resistant 'superbugs'. Novel strategies are therefore urgently needed to combat multi-drug resistant bacterial infection…
with a broad antimicrobial spectrum against multidrug-resistant (MDR) Gram-negative and Gram-positive ‘superbugs’. Octapeptins were discovered over 30 years ago, consequently there is limited information on their…
broad spectrum activity, chip and environmentally safe and potentially used to combat drug-resistanthospital superbugs
bacteria has even been put on top of the WHO list of so-called superbugs for which there is an urgent need to find alternative treatments. Over the past
highest for antibacterial agents in both human and veterinary medicine. The five riskiest superbugs are recognized as: 1. MRSA; 2. the hospital lurkers: C. diff and Acinetobacter; 3. the food
fungi that are resistant to drug cause 700,000 death each year. By 2050 superbugs inured to treatments could cause up to 10 million deaths annually and costs the global
For authors and organisers
Find the right journal for your paper and submit your manuscript.